Wednesday, July 8, 2026

pharma · Acute Myeloid Leukemias · Breast Cancer

Syndax Pharmaceuticals

NovaPharmaNews editorial coverage mentioning Syndax Pharmaceuticals — regulatory, clinical, and market analysis.

730 3rd Ave, Floor 9, New York, NY 10017, US HQ
325 Employees
NMPA registrant Type
Company details
Status
Public
HQ
730 3rd Ave, Floor 9, New York, NY 10017, US
Employees
325
Programs
47
Drugs
29
Patents
6
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Syndax Pharmaceuticals — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Syndax Pharmaceuticals — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Syndax Pharmaceuticals yet.

Back to company overview →